Indivior Pharmaceuticals, Inc. reports

Company location: North Chesterfield, VA
Fiscal year end: 31 December

Indivior Pharmaceuticals, Inc. has filed 548 SEC EDGAR filings since 02 Dec 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
20-F
6-K

SEC filing history

Showing 151-175 of 548 matching filings.

Per page

Current page

SCHEDULE 13D/A File 005-94167

SCHEDULE 13D/A filing

Filing date: 04 Mar 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A File 005-94167

SCHEDULE 13D/A filing

Filing date: 04 Mar 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37835

8-K

Filing date: 04 Mar 2025
Reporting date: 02 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-37835

10-K

Filing date: 03 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

6-K File 001-37835

TOTAL VOTING RIGHTS

Filing date: 03 Mar 2025
Reporting date: 03 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

DIRECTOR/PDMR SHAREHOLDING

Filing date: 28 Feb 2025
Reporting date: 28 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

DIRECTOR/PDMR SHAREHOLDING

Filing date: 28 Feb 2025
Reporting date: 28 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

HOLDING(S) IN COMPANY

Filing date: 28 Feb 2025
Reporting date: 28 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

DIRECTOR/PDMR SHAREHOLDING

Filing date: 27 Feb 2025
Reporting date: 27 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

DIRECTOR/PDMR SHAREHOLDING

Filing date: 27 Feb 2025
Reporting date: 27 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

JOSEPH CIAFFONI APPOINTED CHIEF EXECUTIVE OFFICER

Filing date: 27 Feb 2025
Reporting date: 27 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

HOLDING(S) IN COMPANY

Filing date: 25 Feb 2025
Reporting date: 25 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

FDA APPROVAL OF SUBLOCADE LABEL CHANGES

Filing date: 24 Feb 2025
Reporting date: 24 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K/A File 001-37835

6-K/A

Filing date: 20 Feb 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

6-K

Filing date: 20 Feb 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G/A File 005-94167

SCHEDULE 13G/A filing

Filing date: 13 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

DELAYED FDA APPROVAL OF SUBLOCADE LABEL CHANGES

Filing date: 12 Feb 2025
Reporting date: 12 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G File 005-94167

SCHEDULE 13G filing

Filing date: 06 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

NOTICE OF RESULTS

Filing date: 04 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

COMPLETION OF SHARE REPURCHASE PROGRAM

Filing date: 04 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

TRANSACTION IN OWN SHARES

Filing date: 04 Feb 2025
Reporting date: 04 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

TOTAL VOTING RIGHTS

Filing date: 03 Feb 2025
Reporting date: 03 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

Filing date: 03 Feb 2025
Reporting date: 03 Feb 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

DR. DAVID WHEADON APPOINTED CHAIR OF THE BOARD

Filing date: 28 Jan 2025
Reporting date: 28 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37835

HOLDING(S) IN COMPANY

Filing date: 28 Jan 2025
Reporting date: 28 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing